InnovAge Holding Corp. (INNV)
USD 2.91
(5.43%)
USD 2.91
(5.43%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 56.08 Million USD | 404.57% |
| 2023 | -18.41 Million USD | 81.51% |
| 2022 | -99.61 Million USD | 16.17% |
| 2021 | -118.83 Million USD | -213.12% |
| 2020 | 105.05 Million USD | -22.25% |
| 2019 | 135.11 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | 56.08 Million USD | -3.0% |
| 2024 Q3 | 57.82 Million USD | -0.94% |
| 2024 Q2 | 58.37 Million USD | 229.47% |
| 2024 FY | 56.08 Million USD | 404.57% |
| 2024 Q1 | 17.71 Million USD | 196.2% |
| 2023 Q3 | -10.38 Million USD | -243.72% |
| 2023 Q2 | 7.22 Million USD | 108.95% |
| 2023 FY | -18.41 Million USD | 81.51% |
| 2023 Q1 | -80.74 Million USD | 18.94% |
| 2023 Q4 | -18.41 Million USD | -77.33% |
| 2022 Q2 | -130.98 Million USD | 2.33% |
| 2022 Q4 | -99.61 Million USD | 11.96% |
| 2022 Q3 | -113.15 Million USD | 13.62% |
| 2022 Q1 | -134.11 Million USD | -12.86% |
| 2022 FY | -99.61 Million USD | 16.17% |
| 2021 Q2 | 223.85 Million USD | 0.0% |
| 2021 FY | -118.83 Million USD | -213.12% |
| 2021 Q4 | -118.83 Million USD | -0.36% |
| 2021 Q3 | -118.41 Million USD | -152.9% |
| 2020 Q4 | 105.05 Million USD | 0.0% |
| 2020 FY | 105.05 Million USD | -22.25% |
| 2019 FY | 135.11 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.41 Billion USD | 96.024% |
| Addus HomeCare Corporation | 110.39 Million USD | 49.191% |
| AirSculpt Technologies, Inc. | 89.4 Million USD | 37.265% |
| Amedisys, Inc. | 341.35 Million USD | 83.568% |
| American Oncology Network, Inc. | 99.78 Million USD | 43.791% |
| Astrana Health, Inc. | 27.2 Million USD | -106.157% |
| Aveanna Healthcare Holdings Inc. | 1.45 Billion USD | 96.146% |
| IMAC Holdings, Inc. | -221.51 Thousand USD | 25421.09% |
| biote Corp. | 25.86 Million USD | -116.819% |
| Cryo-Cell International, Inc. | 10.48 Million USD | -434.692% |
| Cross Country Healthcare, Inc. | -11.82 Million USD | 574.245% |
| COMPASS Pathways plc | -187.58 Million USD | 129.9% |
| DocGo Inc. | -12.78 Million USD | 538.572% |
| The Ensign Group, Inc. | 1.36 Billion USD | 95.881% |
| Healthcare Services Group, Inc. | -10.69 Million USD | 624.441% |
| Assure Holdings Corp. | 14.68 Million USD | -282.026% |
| The Joint Corp. | -2.47 Million USD | 2362.146% |
| LifeStance Health Group, Inc. | 432.21 Million USD | 87.023% |
| Mobile-health Network Solutions Class A Ordinary Shares | -6.05 Million USD | 1027.005% |
| ModivCare Inc. | 1.13 Billion USD | 95.068% |
| NewGenIvf Group Limited | 278.44 Thousand USD | -20043.366% |
| Novo Integrated Sciences, Inc. | 4.05 Million USD | -1283.095% |
| Option Care Health, Inc. | 822.56 Million USD | 93.181% |
| P3 Health Partners Inc. | 83.7 Million USD | 32.994% |
| P3 Health Partners Inc. | 83.7 Million USD | 32.994% |
| The Pennant Group, Inc. | 323.57 Million USD | 82.666% |
| Surgery Partners, Inc. | 2.86 Billion USD | 98.043% |
| Syra Health Corp. Class A Common Stock | -3.03 Million USD | 1949.918% |
| Talkspace, Inc. | -123.9 Million USD | 145.267% |
| Talkspace, Inc. | -123.9 Million USD | 145.267% |
| The Oncology Institute, Inc. | 86.32 Million USD | 35.027% |
| The Oncology Institute, Inc. | 86.32 Million USD | 35.027% |